(Q34560322)

3 August 2017

1 reference

title

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality? (English)

1 reference

3 August 2017

1 reference

1 reference

8

Ricardo J Komotar

1 reference

3 August 2017

Ashish H Shah

1

1 reference

3 August 2017

Brian Snelling

2

1 reference

3 August 2017

Amade Bregy

3

1 reference

3 August 2017

Payal R Patel

4

1 reference

3 August 2017

Danoushka Tememe

5

1 reference

3 August 2017

Rita Bhatia

6

1 reference

3 August 2017

Evelyn Sklar

7

1 reference

3 August 2017

publication date

24 January 2013

1 reference

Journal of Neuro-Oncology

3 August 2017

published in

1 reference

3 August 2017

volume

112

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

141-152

1 reference

The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Response criteria for phase II studies of supratentorial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Hyperbaric oxygen therapy for radiation-induced brain injury in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Comparison of glucoheptonate single photon emission computed tomography and contrast-enhanced MRI in detection of recurrent glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spin-labeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differentiation of tumor recurrence from radiation necrosis in high-grade gliomas using 201Tl-SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Clinical impact of (11)C-methionine PET on expected management of patients with brain neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Radiation-induced necrosis deteriorating neurological symptoms and mimicking progression of brain metastasis after stereotactic-guided radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

The use of PET in evaluating patients with primary brain tumours: is it useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Distinguishing recurrent tumor and radiation necrosis with positron emission tomography versus stereotactic biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Diagnostic dilemma of pseudoprogression in the treatment of newly diagnosed glioblastomas: the role of assessing relative cerebral blood flow volume and oxygen-6-methylguanine-DNA methyltransferase promoter methylation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Distinguishing recurrent high-grade gliomas from radiation injury: a pilot study using dynamic contrast-enhanced MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1059-9

Treatment of radiation-induced nervous system injury with heparin and warfarin

21 January 2018

1 reference

12 December 2020

Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study

1 reference

12 December 2020

Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

1 reference

12 December 2020

Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET

1 reference

12 December 2020

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

1 reference

12 December 2020

1 reference

12 December 2020

Cerebral radiation necrosis with accumulation of thallium 201 on single-photon emission CT.

1 reference

12 December 2020

Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis

1 reference

12 December 2020

Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography?

1 reference

12 December 2020

Differentiation between brain tumor recurrence and radiation injury using perfusion, diffusion-weighted imaging and MR spectroscopy

1 reference

12 December 2020

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging

1 reference

12 December 2020

Correlation of histopathological factor of brain tumor and high thallium-201 uptake in single photon emission computed tomography.

1 reference

12 December 2020

Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not.

1 reference

12 December 2020

10.1007/S11060-013-1059-9

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

1010841590

0 references

1 reference